Fernanda O. Novais
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fernanda O. Novais has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Phillip Scott
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA
10 shared publications - Camila Farias Amorim
University of Pennsylvania
5 shared publications - Daniel P. Beiting
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania
5 shared publications - Ba T. Nguyen
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, PA 19104-4539, USA
4 shared publications Camila Farias Amorim
Department of Pathobiology, School of Veterinary Medicine and
4 shared publicationsErin A. Fowler
The Ohio State University
4 shared publications
Latest Publications
- 28 September 2026
- Published by American Society for Microbiology in Microbiology and Molecular Biology Reviews
Beyond the parasite: skin-intrinsic cytolytic circuits drive disease in cutaneous leishmaniasis and reveal targets for host-directed therapy
SUMMARY: Cutaneous leishmaniasis (CL) is a globally prevalent parasitic disease in which tissue pathology often arises primarily from immune-mediated damage rather than uncontrolled parasite replication. Despite effective Th1 responses and the production of IFN-γ, lesions often fail to resolve, highlighting an uncoupling of protective immunity from disease pathogenesis. This review synthesizes evidence from experimental models and human studies demonstrating that skin-intrinsic cytolytic inflammatory circuits—rather than parasite burden—are dominant drivers of lesion persistence and treatment failure in CL. Central to this pathway is the accumulation of cytotoxic CD8 + T cells within lesions, where perforin-dependent cell death triggers NLRP3 inflammasome activation and IL-1β production. IL-1β acts as a potent amplifier of inflammation by promoting neutrophil recruitment, tissue injury, and local hypoxia, which further programs pathogenic CD8 + T-cell differentiation. These responses are exacerbated by alterations of the skin microbiome, particularly the dominance of Staphylococcus aureus , and are normally constrained by Foxp3 + regulatory T cells that limit excessive IFN-γ-driven cytotoxicity. In parallel, parasite persistence within permissive macrophage subsets provides a continuous antigenic stimulus that sustains inflammation without achieving sterilizing immunity. Together, these interconnected pathways form a self-reinforcing inflammatory circuit that promotes ulceration, chronic disease, and therapeutic failure. Importantly, this pathogenic network is largely dispensable for parasite control and, therefore, provides multiple targets for host-directed therapies that could complement anti-parasitic drugs and improve clinical outcomes in CL.
- 28 September 2026
- Published by American Society for Microbiology in Microbiology and Molecular Biology Reviews
Beyond the parasite: skin-intrinsic cytolytic circuits drive disease in cutaneous leishmaniasis and reveal targets for host-directed therapy
SUMMARY: Cutaneous leishmaniasis (CL) is a globally prevalent parasitic disease in which tissue pathology often arises primarily from immune-mediated damage rather than uncontrolled parasite replication. Despite effective Th1 responses and the production of IFN-γ, lesions often fail to resolve, highlighting an uncoupling of protective immunity from disease pathogenesis. This review synthesizes evidence from experimental models and human studies demonstrating that skin-intrinsic cytolytic inflammatory circuits—rather than parasite burden—are dominant drivers of lesion persistence and treatment failure in CL. Central to this pathway is the accumulation of cytotoxic CD8 + T cells within lesions, where perforin-dependent cell death triggers NLRP3 inflammasome activation and IL-1β production. IL-1β acts as a potent amplifier of inflammation by promoting neutrophil recruitment, tissue injury, and local hypoxia, which further programs pathogenic CD8 + T-cell differentiation. These responses are exacerbated by alterations of the skin microbiome, particularly the dominance of Staphylococcus aureus , and are normally constrained by Foxp3 + regulatory T cells that limit excessive IFN-γ-driven cytotoxicity. In parallel, parasite persistence within permissive macrophage subsets provides a continuous antigenic stimulus that sustains inflammation without achieving sterilizing immunity. Together, these interconnected pathways form a self-reinforcing inflammatory circuit that promotes ulceration, chronic disease, and therapeutic failure. Importantly, this pathogenic network is largely dispensable for parasite control and, therefore, provides multiple targets for host-directed therapies that could complement anti-parasitic drugs and improve clinical outcomes in CL.
- Open Access
Hypoxia induces cytotoxicity and suppresses cytokine production by CD8⁺ T cells in cutaneous leishmaniasis.
Cutaneous leishmaniasis is characterized by chronic inflammatory skin lesions in which CD8⁺ T cells exhibit paradoxical functions. While IFN-γ-producing CD8⁺ T cells contribute to the development of protective immunity in the draining lymph node, CD8⁺ T cells recruited to the infected skin lose their ability to produce IFN-γ and instead acquire cytotoxic functions that exacerbate tissue damage. We previously demonstrated that the hypoxic microenvironment of leishmanial lesions promotes CD8⁺ T cell cytotoxicity through induction of Blimp-1. Whether hypoxia also suppresses protective CD8⁺ T cell functions, however, is unknown. Here, we show that hypoxia simultaneously suppresses production of the protective cytokines IFN-γ and TNF-α while enhancing expression of granzyme B and perforin in activated CD8⁺ T cells. In vitro, HIF-1α, but not HIF-2α, was required for hypoxia-induced expression of granzyme B, perforin, and Blimp-1, whereas suppression of IFN-γ and TNF-α occurred independently of HIF signaling, indicating that distinct oxygen-related pathways regulate pathogenic and protective CD8⁺ T cell functions. Hypoxia also increased expression of multiple inhibitory receptors on CD8⁺ T cells, although lesional CD8⁺ T cells lacked expression of the terminal exhaustion-associated transcription factor TOX, suggesting that hypoxia promotes an inhibitory phenotype distinct from terminal exhaustion. Finally, adoptive transfer studies demonstrated that in vivo both HIF-1α and HIF-2α expression in CD8⁺ T cells contributed to immunopathology during cutaneous leishmaniasis. Together, these findings identify hypoxia as a key regulator that functionally reprograms CD8⁺ T cells by promoting pathogenic cytotoxicity while suppressing protective cytokine production within lesions.
Open AccessHypoxia induces cytotoxicity and suppresses cytokine production by CD8⁺ T cells in cutaneous leishmaniasis.
Cutaneous leishmaniasis is characterized by chronic inflammatory skin lesions in which CD8⁺ T cells exhibit paradoxical functions. While IFN-γ-producing CD8⁺ T cells contribute to the development of protective immunity in the draining lymph node, CD8⁺ T cells recruited to the infected skin lose their ability to produce IFN-γ and instead acquire cytotoxic functions that exacerbate tissue damage. We previously demonstrated that the hypoxic microenvironment of leishmanial lesions promotes CD8⁺ T cell cytotoxicity through induction of Blimp-1. Whether hypoxia also suppresses protective CD8⁺ T cell functions, however, is unknown. Here, we show that hypoxia simultaneously suppresses production of the protective cytokines IFN-γ and TNF-α while enhancing expression of granzyme B and perforin in activated CD8⁺ T cells. In vitro, HIF-1α, but not HIF-2α, was required for hypoxia-induced expression of granzyme B, perforin, and Blimp-1, whereas suppression of IFN-γ and TNF-α occurred independently of HIF signaling, indicating that distinct oxygen-related pathways regulate pathogenic and protective CD8⁺ T cell functions. Hypoxia also increased expression of multiple inhibitory receptors on CD8⁺ T cells, although lesional CD8⁺ T cells lacked expression of the terminal exhaustion-associated transcription factor TOX, suggesting that hypoxia promotes an inhibitory phenotype distinct from terminal exhaustion. Finally, adoptive transfer studies demonstrated that in vivo both HIF-1α and HIF-2α expression in CD8⁺ T cells contributed to immunopathology during cutaneous leishmaniasis. Together, these findings identify hypoxia as a key regulator that functionally reprograms CD8⁺ T cells by promoting pathogenic cytotoxicity while suppressing protective cytokine production within lesions.
- Open Access
Acriflavine attenuates inflammatory pathology in cutaneous leishmaniasis independently of parasite control
Cutaneous leishmaniasis is a parasitic skin disease for which current treatments often fail, highlighting the need for new therapeutic approaches. While high parasite burdens are associated with delayed healing, excessive protective immune responses, including elevated IFN-γ production, have also been linked to worse clinical outcomes, indicating that immunopathology contributes significantly to disease progression. Acriflavine is an antimicrobial compound with reported anti-leishmanial activity and the ability to inhibit hypoxia-driven responses. Because Leishmania -infected skin is hypoxic in both mice and humans, and hypoxia has been implicated in disease pathogenesis, we investigated whether acriflavine alters the course of cutaneous leishmaniasis by affecting parasite control and/or host immune responses. We found that acriflavine treatment significantly reduced lesion size in Leishmania major -infected mice. Unexpectedly, this improvement occurred without changes in parasite burden. Instead, acriflavine treatment reduced the frequency of dendritic cells within lesions and decreased their expression of MHC class II, which correlated with fewer IFN-γ-producing CD4 T cells at the site of infection. These findings indicate that acriflavine ameliorates disease by limiting dendritic cell activation and subsequent IFN-γ-driven immunopathology rather than enhancing parasite clearance. Together, our results identify acriflavine as a potential host-directed therapeutic strategy for cutaneous leishmaniasis and support targeting hypoxia-associated pathways to reduce tissue damage driven by excessive inflammatory responses.
Open AccessAcriflavine attenuates inflammatory pathology in cutaneous leishmaniasis independently of parasite control
Cutaneous leishmaniasis is a parasitic skin disease for which current treatments often fail, highlighting the need for new therapeutic approaches. While high parasite burdens are associated with delayed healing, excessive protective immune responses, including elevated IFN-γ production, have also been linked to worse clinical outcomes, indicating that immunopathology contributes significantly to disease progression. Acriflavine is an antimicrobial compound with reported anti-leishmanial activity and the ability to inhibit hypoxia-driven responses. Because Leishmania -infected skin is hypoxic in both mice and humans, and hypoxia has been implicated in disease pathogenesis, we investigated whether acriflavine alters the course of cutaneous leishmaniasis by affecting parasite control and/or host immune responses. We found that acriflavine treatment significantly reduced lesion size in Leishmania major -infected mice. Unexpectedly, this improvement occurred without changes in parasite burden. Instead, acriflavine treatment reduced the frequency of dendritic cells within lesions and decreased their expression of MHC class II, which correlated with fewer IFN-γ-producing CD4 T cells at the site of infection. These findings indicate that acriflavine ameliorates disease by limiting dendritic cell activation and subsequent IFN-γ-driven immunopathology rather than enhancing parasite clearance. Together, our results identify acriflavine as a potential host-directed therapeutic strategy for cutaneous leishmaniasis and support targeting hypoxia-associated pathways to reduce tissue damage driven by excessive inflammatory responses.
- Open Access
- 8 October 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (10) , e0353723
Step-by-step: the CD8 T cell journey in leishmaniasis
Leishmaniasis is a group of vector-borne diseases caused by protozoan parasites of the genus Leishmania that affect millions of people across nearly 100 countries. Clinical presentations range from self-resolving cutaneous ulcers to life-threatening visceral disease, depending on the infecting species and host immune response. While CD4 T cells have long been recognized as central to parasite control, CD8 T cells also play an important role in disease. In this mini-review, we explore the many steps involved in CD8 T cell responses in leishmaniasis, with a focus on antigen recognition, recruitment, effector function, memory development, and dysfunction. Drawing on both murine models and human studies, we highlight the duality of CD8 T cells, which can contribute to protection but also drive immune-mediated tissue damage. Recent advances in transcriptomics, in vivo modeling, and immunophenotyping have begun to clarify the conditions under which CD8 T cells support vs hinder host defense. Despite this progress, critical questions remain, and continued investigation into the heterogeneity and regulation of CD8 T cells in leishmaniasis promises not only to deepen our understanding of host-pathogen interactions but also to guide the development of targeted immunotherapies and vaccines.
- 8 October 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (10) , e0353723
Open AccessStep-by-step: the CD8 T cell journey in leishmaniasis
Leishmaniasis is a group of vector-borne diseases caused by protozoan parasites of the genus Leishmania that affect millions of people across nearly 100 countries. Clinical presentations range from self-resolving cutaneous ulcers to life-threatening visceral disease, depending on the infecting species and host immune response. While CD4 T cells have long been recognized as central to parasite control, CD8 T cells also play an important role in disease. In this mini-review, we explore the many steps involved in CD8 T cell responses in leishmaniasis, with a focus on antigen recognition, recruitment, effector function, memory development, and dysfunction. Drawing on both murine models and human studies, we highlight the duality of CD8 T cells, which can contribute to protection but also drive immune-mediated tissue damage. Recent advances in transcriptomics, in vivo modeling, and immunophenotyping have begun to clarify the conditions under which CD8 T cells support vs hinder host defense. Despite this progress, critical questions remain, and continued investigation into the heterogeneity and regulation of CD8 T cells in leishmaniasis promises not only to deepen our understanding of host-pathogen interactions but also to guide the development of targeted immunotherapies and vaccines.
- Open Access
- 8 July 2025
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 93 (7) , e0050424
Oxygen and immunity to Leishmania infection
Oxygen availability plays a fundamental role in shaping immune responses to infections. Leishmaniasis, a disease caused by protozoan parasites of the genus Leishmania , manifests in a spectrum of clinical outcomes, ranging from localized cutaneous lesions to life-threatening visceral infections. Like many infections and chronic diseases, Leishmania -infected tissues are characterized by hypoxia. Despite the recognized importance of oxygen in immune regulation, our understanding of how hypoxia shapes the immune landscape in leishmaniasis remains in its early stages. Collectively, the published studies in leishmaniasis highlight the critical role of oxygen availability and hypoxia-inducible factor (HIF) in orchestrating immune responses, particularly within myeloid cells. Here, we review the literature on how oxygen availability and HIF signaling influence the immune response in leishmaniasis. By consolidating existing findings and identifying gaps in knowledge, we aim to inspire further research into the interplay between oxygen availability, immune function, disease progression, and therapeutic potential in leishmaniasis.
- 8 July 2025
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 93 (7) , e0050424
Open AccessOxygen and immunity to Leishmania infection
Oxygen availability plays a fundamental role in shaping immune responses to infections. Leishmaniasis, a disease caused by protozoan parasites of the genus Leishmania , manifests in a spectrum of clinical outcomes, ranging from localized cutaneous lesions to life-threatening visceral infections. Like many infections and chronic diseases, Leishmania -infected tissues are characterized by hypoxia. Despite the recognized importance of oxygen in immune regulation, our understanding of how hypoxia shapes the immune landscape in leishmaniasis remains in its early stages. Collectively, the published studies in leishmaniasis highlight the critical role of oxygen availability and hypoxia-inducible factor (HIF) in orchestrating immune responses, particularly within myeloid cells. Here, we review the literature on how oxygen availability and HIF signaling influence the immune response in leishmaniasis. By consolidating existing findings and identifying gaps in knowledge, we aim to inspire further research into the interplay between oxygen availability, immune function, disease progression, and therapeutic potential in leishmaniasis.
- Open Access
- 13 May 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (12) , 3145-3157.e1
Hypoxia and IL-15 Cooperate to Induce Perforin Expression by CD8 T Cells and Promote Damage to the Skin in Murine Cutaneous Leishmaniasis
- 13 May 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (12) , 3145-3157.e1
Open AccessHypoxia and IL-15 Cooperate to Induce Perforin Expression by CD8 T Cells and Promote Damage to the Skin in Murine Cutaneous Leishmaniasis
- Open Access
- 4 June 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (14)
Neutrophil-mediated hypoxia drives pathogenic CD8+ T cell responses in cutaneous leishmaniasis
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical manifestations. Although parasites influence disease severity, cytolytic CD8 + T cell responses mediate disease. Although these responses originate in the lymph node, we found that expression of the cytolytic effector molecule granzyme B was restricted to lesional CD8 + T cells in Leishmania -infected mice, suggesting that local cues within inflamed skin induced cytolytic function. Expression of Blimp-1 ( Prdm1 ), a transcription factor necessary for cytolytic CD8 + T cell differentiation, was driven by hypoxia within the inflamed skin. Hypoxia was further enhanced by the recruitment of neutrophils that consumed oxygen to produce ROS and ultimately increased the hypoxic state and granzyme B expression in CD8 + T cells. Importantly, lesions from patients with cutaneous leishmaniasis exhibited hypoxia transcription signatures that correlated with the presence of neutrophils. Thus, targeting hypoxia-driven signals that support local differentiation of cytolytic CD8 + T cells may improve the prognosis for patients with cutaneous leishmaniasis, as well as for other inflammatory skin diseases in which cytolytic CD8 + T cells contribute to pathogenesis.
- 4 June 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (14)
Open AccessNeutrophil-mediated hypoxia drives pathogenic CD8+ T cell responses in cutaneous leishmaniasis
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical manifestations. Although parasites influence disease severity, cytolytic CD8 + T cell responses mediate disease. Although these responses originate in the lymph node, we found that expression of the cytolytic effector molecule granzyme B was restricted to lesional CD8 + T cells in Leishmania -infected mice, suggesting that local cues within inflamed skin induced cytolytic function. Expression of Blimp-1 ( Prdm1 ), a transcription factor necessary for cytolytic CD8 + T cell differentiation, was driven by hypoxia within the inflamed skin. Hypoxia was further enhanced by the recruitment of neutrophils that consumed oxygen to produce ROS and ultimately increased the hypoxic state and granzyme B expression in CD8 + T cells. Importantly, lesions from patients with cutaneous leishmaniasis exhibited hypoxia transcription signatures that correlated with the presence of neutrophils. Thus, targeting hypoxia-driven signals that support local differentiation of cytolytic CD8 + T cells may improve the prognosis for patients with cutaneous leishmaniasis, as well as for other inflammatory skin diseases in which cytolytic CD8 + T cells contribute to pathogenesis.
- Open Access
Pathogenic CD8 T cell responses are driven by neutrophil-mediated hypoxia in cutaneous leishmaniasis
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical manifestations. Although parasites influence disease severity, cytolytic CD8 T cell responses mediate disease. While these responses originate in the lymph node, we find that expression of the cytolytic effector molecule granzyme B is restricted to lesional CD8 T cells in Leishmania - infected mice, suggesting that local cues within inflamed skin induce cytolytic function. Expression of Blimp-1 ( Prdm1 ), a transcription factor necessary for cytolytic CD8 T cell differentiation, is driven by hypoxia within the inflamed skin. Hypoxia is further enhanced by the recruitment of neutrophils that consume oxygen to produce reactive oxygen species, ultimately increasing granzyme B expression in CD8 T cells. Importantly, lesions from cutaneous leishmaniasis patients exhibit hypoxia transcription signatures that correlate with the presence of neutrophils. Thus, targeting hypoxia-driven signals that support local differentiation of cytolytic CD8 T cells may improve the prognosis for patients with cutaneous leishmaniasis, as well as other inflammatory skin diseases where cytolytic CD8 T cells contribute to pathogenesis.
Open AccessPathogenic CD8 T cell responses are driven by neutrophil-mediated hypoxia in cutaneous leishmaniasis
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical manifestations. Although parasites influence disease severity, cytolytic CD8 T cell responses mediate disease. While these responses originate in the lymph node, we find that expression of the cytolytic effector molecule granzyme B is restricted to lesional CD8 T cells in Leishmania - infected mice, suggesting that local cues within inflamed skin induce cytolytic function. Expression of Blimp-1 ( Prdm1 ), a transcription factor necessary for cytolytic CD8 T cell differentiation, is driven by hypoxia within the inflamed skin. Hypoxia is further enhanced by the recruitment of neutrophils that consume oxygen to produce reactive oxygen species, ultimately increasing granzyme B expression in CD8 T cells. Importantly, lesions from cutaneous leishmaniasis patients exhibit hypoxia transcription signatures that correlate with the presence of neutrophils. Thus, targeting hypoxia-driven signals that support local differentiation of cytolytic CD8 T cells may improve the prognosis for patients with cutaneous leishmaniasis, as well as other inflammatory skin diseases where cytolytic CD8 T cells contribute to pathogenesis.
- 18 October 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (718) , eadh1469
Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity
Leishmania braziliensis is a parasitic infection that can result in inflammation and skin injury with highly variable and unpredictable clinical outcomes. Here, we investigated the potential impact of microbiota on infection-induced inflammatory responses and disease resolution by conducting an integrated analysis of the skin microbiome and host transcriptome on a cohort of 62 patients infected with L. braziliensis . We found that overall bacterial burden and microbiome configurations dominated with Staphylococcus spp. were associated with delayed healing and enhanced inflammatory responses, especially by IL-1 family members. Quantification of host and bacterial transcripts on human lesions revealed that high lesional S. aureus transcript abundance was associated with delayed healing and increased expression of IL-1β. This cytokine was critical for modulating disease outcomes in L. braziliensis –infected mice colonized with S. aureus , given that its neutralization reduced pathology and inflammation. These results highlight how the human microbiome can shape disease outcomes in cutaneous leishmaniasis and suggest pathways toward host-directed therapies to mitigate the inflammatory consequences.
- 18 October 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (718) , eadh1469
Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity
Leishmania braziliensis is a parasitic infection that can result in inflammation and skin injury with highly variable and unpredictable clinical outcomes. Here, we investigated the potential impact of microbiota on infection-induced inflammatory responses and disease resolution by conducting an integrated analysis of the skin microbiome and host transcriptome on a cohort of 62 patients infected with L. braziliensis . We found that overall bacterial burden and microbiome configurations dominated with Staphylococcus spp. were associated with delayed healing and enhanced inflammatory responses, especially by IL-1 family members. Quantification of host and bacterial transcripts on human lesions revealed that high lesional S. aureus transcript abundance was associated with delayed healing and increased expression of IL-1β. This cytokine was critical for modulating disease outcomes in L. braziliensis –infected mice colonized with S. aureus , given that its neutralization reduced pathology and inflammation. These results highlight how the human microbiome can shape disease outcomes in cutaneous leishmaniasis and suggest pathways toward host-directed therapies to mitigate the inflammatory consequences.
- Open Access
- 21 August 2023
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 17 (8) , e0011552
NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
Cutaneous leishmaniasis exhibits a spectrum of clinical presentations dependent upon the parasites’ persistence and host immunopathologic responses. Although cytolytic CD8 T cells cannot control the parasites, they significantly contribute to pathologic responses. In a murine model of cutaneous leishmaniasis, we previously found that NKG2D plays a role in the ability of cytolytic CD8 T cells to promote disease in leishmanial lesions. Here, we investigated whether NKG2D plays a role in human disease. We found that NKG2D and its ligands were expressed within lesions from L. braziliensis-infected patients and that IL-15 and IL-1β were factors driving NKG2D and NKG2D ligand expression, respectively. Blocking NKG2D reduced degranulation by CD8 T cells in a subset of patients. Additionally, our transcriptional analysis of patients’ lesions found that patients who failed the first round of treatment exhibited higher expression of KLRK1, the gene coding for NKG2D, than those who responded to treatment. These findings suggest that NKG2D may be a promising therapeutic target for ameliorating disease severity in cutaneous leishmaniasis caused by L. braziliensis infection.
- 21 August 2023
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 17 (8) , e0011552
Open AccessNKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
Cutaneous leishmaniasis exhibits a spectrum of clinical presentations dependent upon the parasites’ persistence and host immunopathologic responses. Although cytolytic CD8 T cells cannot control the parasites, they significantly contribute to pathologic responses. In a murine model of cutaneous leishmaniasis, we previously found that NKG2D plays a role in the ability of cytolytic CD8 T cells to promote disease in leishmanial lesions. Here, we investigated whether NKG2D plays a role in human disease. We found that NKG2D and its ligands were expressed within lesions from L. braziliensis-infected patients and that IL-15 and IL-1β were factors driving NKG2D and NKG2D ligand expression, respectively. Blocking NKG2D reduced degranulation by CD8 T cells in a subset of patients. Additionally, our transcriptional analysis of patients’ lesions found that patients who failed the first round of treatment exhibited higher expression of KLRK1, the gene coding for NKG2D, than those who responded to treatment. These findings suggest that NKG2D may be a promising therapeutic target for ameliorating disease severity in cutaneous leishmaniasis caused by L. braziliensis infection.